U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: June 14-20, 2020
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: June 14-20, 2020

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs

Event Date: 06/18/2020
Location: Virtual
Subject: Medical Device Innovation Consortium Annual Public Forum
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Media, industry, government, and other registered guests

Event Date: 06/18/2020
Location: Virtual
Subject: US FDA - European Medicines Agency 2020 Bilateral Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Members of the European Commission and the European Medicines Agency

Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner

Event Date: 06/15/2020
Location: Virtual
Subject: Jerusalem Ethics Forum Webinar: Ethical Dilemmas and Responsibility of Regulators During a Pandemic
FDA Participant/Group: N/A
Non FDA Participant/Group: Providers, industry, academia, and other stakeholders

Event Date: 06/16/2020
Location: Virtual
Subject: Health Data Research UK: Virtual Conference
FDA Participant/Group: N/A
Non FDA Participant/Group: Academics, patients, providers, government, and other stakeholders

Event Date: 06/18/2020
Location: Virtual
Subject: Reagan-Udall Foundation: COVID-19 Evidence Accelerator Collaborative Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Patient groups, providers, industry, academia, and other stakeholders

Official Name: Anand Shah, M.D., Deputy Commissioner for Medical and Scientific Affairs

Event Date: 06/18/2020
Location: Virtual
Subject: Clinical Trials Transformation Initiative (CTTI) Webinar: Engaging Diverse Populations in COVID-19 Trials
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives from industry, academia, government, and other stakeholders

Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 06/17/2020
Location: Virtual
Subject: United Fresh Live Webinar on Food Safety
FDA Participant/Group: N/A
Non FDA Participant/Group: Members from across the produce industry

Event Date: 06/17/2020
Location: Virtual
Subject: Food Supply Chain Continuity and Food Worker/Migrant Worker Safety
FDA Participant/Group: Several FDA officials and staff
Non FDA Participant/Group: Several members from Indiana State Departments of Health and Agriculture

Event Date: 06/18/2020
Location: Virtual
Subject: Food Supply Chain Continuity and Food Worker/Migrant Worker Safety
FDA Participant/Group: Several FDA officials and staff
Non FDA Participant/Group: Several members from Wisconsin's State Departments of Health and Agriculture

Event Date: 06/18/2020
Location: Virtual
Subject: Food Supply Chain Continuity and Food Worker/Migrant Worker Safety
FDA Participant/Group: Several FDA officials and staff
Non FDA Participant/Group: Several members from Minnesota's State Departments of Health and Agriculture

Event Date: 06/19/2020
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: Hilary Thesmar , Leslie Sarasin (Food Marketing Institute);

Event Date: 06/19/2020
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: Alison Bodor ( American Frozen Food Institute ); Robb MacKie (American Bakers Association );

Official Name: Lowell Schiller, Principal Associate Commissioner for Policy

Event Date: 06/15/2020
Location: WEBEX
Subject: Listening Session for FDA Staff: Hemp and Cannabinoid Science Institute
FDA Participant/Group: KAREN MEISTER; PATRICK COURNOYER; STEVEN TAVE; CHARLOTTE CONWAY; AMY ABERNETHY; NAKISSA SADRIEH; DOUGLAS THROCKMORTON; TYNA DAO; SHERENE SEPEHRI; PATRICK CANNON; SHARON MAYL; ERIK METTLER; LINDA KATZ; DOMINIC CHIAPPERINO; PAUL HART; MICHELLE ADAMS; APRIL ALEXANDROW; RANDALL GNATT;
Non FDA Participant/Group: Karil Kochenderfer, Mary Wagner, Scott Riefler (Hemp and Cannabinoid Science Institute);

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Laura Caliguiri, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Acting Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 06/16/2020
Location: Virtual
Subject: Critical Need for Harmonized Post-marketing Surveillance in Gene Therapy: FDA Gene Therapy Guidelines
FDA Participant/Group: N/A
Non FDA Participant/Group: Multidisciplinary members of the bleeding disorders community

Event Date: 06/19/2020
Location: Virtual
Subject: COVID-19 Vaccines & Individualized (Bespoke) Therapies
FDA Participant/Group: Several FDA officials and staff
Non FDA Participant/Group: Several representatives from the European Commission-European Medicines Agency

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 06/19/2020
Location: Teleconference
Subject: SARS-CoV-2 Testing Platforms
FDA Participant/Group: ELIZABETH HILLEBRENNER; ELLEN FLANNERY; JENNIFER TOMASELLO; JONATHAN HODNETTE; MATTHEW DIAMOND; MICHAEL VARDON; JULIA TIERNEY; TOBY LOWE; TIMOTHY STENZEL; DIANE MALONEY; CAROLYN WILSON; YASEMIN LUEBKE;
Non FDA Participant/Group: Alan Slodobin, Brittany Havens, Diane Cutler, Jennifer Barblan, Kristin Seum, Natalie Sohn (Energy and Commerce Oversight, Staff);

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

Event Date: 06/17/2020
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: Animal Health Institute (AHI)

Event Date: 06/18/2020
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: SIOBHAN DELANCEY; NADINE STEINBERG; NEAL BATALLER; ANNE NORRIS; CLAUDINE KABERA; TIMOTHY SCHELL; MARGARET OELLER; PATRICK MCDERMOTT; SHANNON RUTHERFORD; KEVIN GREENLEES; SUSAN BRIGHT-PONTE; CINDY BURNSTEEL; TRACEY FORFA; WILLIAM FLYNN; ANTONIA MONIQUE SENNETT; REGINA TAN; ASHLEY STEEL;
Non FDA Participant/Group: Representatives from The Pew Charitable Trusts

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event

 

Back to Top